AI assistant
RESMED INC — Director's Dealing 2025
Nov 13, 2025
30071_dirs_2025-11-13_72af1f56-872e-491d-9fcb-a8d5eeca8e3c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-11-11
Reporting Person: Rider Michael J (Global General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | ResMed Common Stock | F | 135.075 | $250.10 | Disposed | 11231 | Direct |
| 2025-11-11 | ResMed Common Stock | F | 173.725 | $250.10 | Disposed | 11057 | Direct |
| 2025-11-11 | ResMed Common Stock | F | 715.489 | $250.10 | Disposed | 10342 | Direct |
| 2025-11-11 | ResMed Common Stock | F | 500.735 | $250.10 | Disposed | 9841 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.
F2: Includes 38.9396 shares of ResMed stock purchased on October 31, 2025, through the ResMed Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
F4: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
F5: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.